By Aaron Tallent
There is a significant lag time before determining the appropriate dosing regimen for new antibacterial agents given to children, according to a presentation ASM Microbe 2022, the annual meeting of American Society for Microbiology, held in Washington, DC.
Of the 24 approved antimicrobials, 20 were for use in adults alone for indications that included acute bacterial skin infections and community-acquired pneumonia. Of those 20, six were approved and labeled for patients younger